IBS patients respond differently to placebo analgesic, study says

06/4/2014 | Medscape (free registration)

Irritable bowel syndrome patients undergoing painful stimuli were less able to down-regulate the pain when given a placebo analgesic, compared with healthy people and ulcerative colitis patients in remission, German researchers reported. The study also showed that IBS patients who had greater levels of depressive symptoms had a weaker response to placebo analgesia. Interest in placebo analgesia was sparked by a 2008 study that suggested placebo acupuncture was effective in IBS.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN